vs

Side-by-side financial comparison of Editas Medicine, Inc. (EDIT) and La Rosa Holdings Corp. (LRHC). Click either name above to swap in a different company.

Editas Medicine, Inc. is the larger business by last-quarter revenue ($24.7M vs $20.2M, roughly 1.2× La Rosa Holdings Corp.). Editas Medicine, Inc. runs the higher net margin — -22.7% vs -27.4%, a 4.7% gap on every dollar of revenue. On growth, La Rosa Holdings Corp. posted the faster year-over-year revenue change (3.2% vs -19.2%). Over the past eight quarters, Editas Medicine, Inc.'s revenue compounded faster (366.9% CAGR vs 72.5%).

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

V. La Rosa and Sons Macaroni Company was founded in 1914 by Vincenzo La Rosa, a Sicilian immigrant. The company eventually became one of the largest regional brands in the United States producing over 40 varieties of pasta.

EDIT vs LRHC — Head-to-Head

Bigger by revenue
EDIT
EDIT
1.2× larger
EDIT
$24.7M
$20.2M
LRHC
Growing faster (revenue YoY)
LRHC
LRHC
+22.3% gap
LRHC
3.2%
-19.2%
EDIT
Higher net margin
EDIT
EDIT
4.7% more per $
EDIT
-22.7%
-27.4%
LRHC
Faster 2-yr revenue CAGR
EDIT
EDIT
Annualised
EDIT
366.9%
72.5%
LRHC

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
EDIT
EDIT
LRHC
LRHC
Revenue
$24.7M
$20.2M
Net Profit
$-5.6M
$-5.5M
Gross Margin
8.4%
Operating Margin
-31.3%
-24.7%
Net Margin
-22.7%
-27.4%
Revenue YoY
-19.2%
3.2%
Net Profit YoY
87.6%
-125.7%
EPS (diluted)
$0.03
$-5.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EDIT
EDIT
LRHC
LRHC
Q4 25
$24.7M
Q3 25
$7.5M
$20.2M
Q2 25
$3.6M
$23.2M
Q1 25
$4.7M
$17.5M
Q4 24
$30.6M
$17.7M
Q3 24
$61.0K
$19.6M
Q2 24
$513.0K
$19.1M
Q1 24
$1.1M
$13.1M
Net Profit
EDIT
EDIT
LRHC
LRHC
Q4 25
$-5.6M
Q3 25
$-25.1M
$-5.5M
Q2 25
$-53.2M
$78.4M
Q1 25
$-76.1M
$-95.7M
Q4 24
$-45.4M
$-5.1M
Q3 24
$-62.1M
$-2.5M
Q2 24
$-67.6M
$-2.3M
Q1 24
$-62.0M
$-4.6M
Gross Margin
EDIT
EDIT
LRHC
LRHC
Q4 25
Q3 25
8.4%
Q2 25
8.0%
Q1 25
8.8%
Q4 24
8.9%
Q3 24
8.3%
Q2 24
8.3%
Q1 24
8.9%
Operating Margin
EDIT
EDIT
LRHC
LRHC
Q4 25
-31.3%
Q3 25
-325.4%
-24.7%
Q2 25
-1440.6%
-10.6%
Q1 25
-1635.1%
-26.7%
Q4 24
-152.2%
-17.1%
Q3 24
-107649.2%
-8.9%
Q2 24
-14016.2%
-9.7%
Q1 24
-5902.3%
-35.0%
Net Margin
EDIT
EDIT
LRHC
LRHC
Q4 25
-22.7%
Q3 25
-333.0%
-27.4%
Q2 25
-1487.8%
337.8%
Q1 25
-1633.5%
-546.5%
Q4 24
-148.3%
-28.7%
Q3 24
-101870.5%
-12.5%
Q2 24
-13178.8%
-12.2%
Q1 24
-5458.1%
-35.1%
EPS (diluted)
EDIT
EDIT
LRHC
LRHC
Q4 25
$0.03
Q3 25
$-0.28
$-5.44
Q2 25
$-0.63
$15.25
Q1 25
$-0.92
$-5.86
Q4 24
$-0.55
$28.54
Q3 24
$-0.75
$-16.49
Q2 24
$-0.82
$-12.49
Q1 24
$-0.76
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EDIT
EDIT
LRHC
LRHC
Cash + ST InvestmentsLiquidity on hand
$146.6M
$4.0M
Total DebtLower is stronger
$642.8K
Stockholders' EquityBook value
$27.3M
$1.6M
Total Assets
$186.5M
$21.7M
Debt / EquityLower = less leverage
0.41×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EDIT
EDIT
LRHC
LRHC
Q4 25
$146.6M
Q3 25
$165.6M
$4.0M
Q2 25
$178.5M
$5.1M
Q1 25
$221.0M
$2.9M
Q4 24
$269.9M
$1.4M
Q3 24
$265.1M
$1.8M
Q2 24
$279.1M
$1.6M
Q1 24
$296.2M
$1.1M
Total Debt
EDIT
EDIT
LRHC
LRHC
Q4 25
Q3 25
$642.8K
Q2 25
$644.3K
Q1 25
$645.9K
Q4 24
$57.4M
$647.6K
Q3 24
$649.2K
Q2 24
$650.8K
Q1 24
$652.4K
Stockholders' Equity
EDIT
EDIT
LRHC
LRHC
Q4 25
$27.3M
Q3 25
$13.5M
$1.6M
Q2 25
$19.2M
$3.4M
Q1 25
$62.4M
$-87.5M
Q4 24
$134.3M
$2.6M
Q3 24
$175.6M
$5.0M
Q2 24
$232.0M
$4.7M
Q1 24
$294.4M
$5.6M
Total Assets
EDIT
EDIT
LRHC
LRHC
Q4 25
$186.5M
Q3 25
$201.8M
$21.7M
Q2 25
$210.6M
$22.9M
Q1 25
$263.7M
$21.0M
Q4 24
$341.6M
$19.4M
Q3 24
$327.6M
$19.7M
Q2 24
$384.8M
$18.7M
Q1 24
$440.3M
$16.3M
Debt / Equity
EDIT
EDIT
LRHC
LRHC
Q4 25
Q3 25
0.41×
Q2 25
0.19×
Q1 25
Q4 24
0.43×
0.25×
Q3 24
0.13×
Q2 24
0.14×
Q1 24
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EDIT
EDIT
LRHC
LRHC
Operating Cash FlowLast quarter
$-36.4M
$-1.3M
Free Cash FlowOCF − Capex
$-36.4M
FCF MarginFCF / Revenue
-147.3%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EDIT
EDIT
LRHC
LRHC
Q4 25
$-36.4M
Q3 25
$-30.8M
$-1.3M
Q2 25
$-50.2M
$-1.4M
Q1 25
$-47.8M
$-3.5M
Q4 24
$-50.8M
$-1.1M
Q3 24
$-52.6M
$-591.6K
Q2 24
$-57.1M
$-803.1K
Q1 24
$-49.9M
$-538.3K
Free Cash Flow
EDIT
EDIT
LRHC
LRHC
Q4 25
$-36.4M
Q3 25
$-31.3M
Q2 25
Q1 25
$-47.9M
Q4 24
$-51.3M
Q3 24
$-55.5M
Q2 24
$-60.6M
Q1 24
$-51.7M
FCF Margin
EDIT
EDIT
LRHC
LRHC
Q4 25
-147.3%
Q3 25
-414.6%
Q2 25
Q1 25
-1028.6%
Q4 24
-167.6%
Q3 24
-90998.4%
Q2 24
-11804.3%
Q1 24
-4558.9%
Capex Intensity
EDIT
EDIT
LRHC
LRHC
Q4 25
0.2%
Q3 25
5.7%
Q2 25
0.0%
Q1 25
2.4%
Q4 24
1.8%
Q3 24
4788.5%
Q2 24
681.1%
Q1 24
164.8%
Cash Conversion
EDIT
EDIT
LRHC
LRHC
Q4 25
Q3 25
Q2 25
-0.02×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EDIT
EDIT

Segment breakdown not available.

LRHC
LRHC

Real Estate Residential Brokerage Services$16.8M83%
Transferred Over Time$3.5M17%

Related Comparisons